Introducing the World's First and Only Dual Chamber Leadless Pacemaker System
Brought to you only by Abbott, the AVEIR DR Dual Chamber Leadless Pacemaker (LP) System is first-of-its-kind technology that provides:
- Beat-to-Beat Synchrony between both chambers.1,2
- Upgradeable from single to dual chamber therapy.1
- Long-Term Retrieval to remove hardware at end of service (EOS).1,3
- Electrical Mapping Before Fixation to reduce repositioning.1,2
Our life-changing technology provides all the clinical benefits of traditional dual chamber pacemakers without the downsides. This means:
- NO pocket- and lead-related complications (including infection, lead fracture, insulation problems, skin erosion and keloid formation).
- NO visible scarring.
- NO arm movement restrictions post-implantation.
Beat-to-Beat Synchrony1,2
AVEIR™ DR Leadless Pacemaker System is capable of pacing and sensing in both chambers through the combination of an atrial leadless pacemaker (AVEIR™ AR LP) and a ventricular leadless pacemaker (AVEIR™ VR LP).
Dual chamber, leadless synchronous pacing between the atrium and the ventricle is made possible with industry-first, proprietary i2i™ communication technology capable of providing true DDD(R) pacing for continuous, atrioventricular (AV) synchrony, regardless of patient posture.
Mean AV synchrony observed for multiple postures and gaits (including sitting, supine, left lateral recumbent, right lateral recumbent, standing, normal walking and fast walking).2
Implant-to-Implant (i2i™) Technology1
This novel technology features paired, co-implanted devices employing low-energy, subthreshold pulses between them using the conductive nature of the body’s blood pool and myocardial tissue.
High-frequency pulses are delivered concurrently with each locally paced or sensed event without impact on pacing or intrinsic sensing.
Upgradeable System1
Patient therapy can be tailored by implanting an atrial or ventricular device alone, or both combined, for dual chamber support. The option to upgrade over time allows you to:
- Meet your patients’ needs today
- Adapt to common disease progression to meet your patients’ needs in the future
Option to Start with Atrial Pacing
Treat sinus node dysfunction today.
Add Ventricular Pacing Later
Treat those same patients by adding a ventricular device if heart block develops later to provide DDD(R) or AAI(R)+VVI therapy
Achieve Dual Chamber Pacing
Now you have options to adapt to patient needs over time.
Tailored Therapy for Your Leadless Patients
The AAI(R) + VVI Pacing Mode, available for new and existing sinus node dysfunction patients with intact AV conduction, provides increased atrial and ventricular device longevities with beat-to-beat communications turned off and offers primary atrial pacing support with ventricular back-up.1,†
Up To 70% Increased Atrial Device Longevity
with AAI(R) + VVI Pacing Mode
With beat-to-beat communications turned off, up to 70% increase in projected atrial device longevity compared to DDD(R).5,*
† Note: AAI(R)+VVI mode should not be used in patients without intact AV node conduction, or with chronic atrial fibrillation or atrial flutter.
Long-term Retrieval1,3,4
This allows for the replacement of the atrial or ventricular device at end of service (EOS) without leaving hardware behind.
The AVEIR™ VR Ventricular Leadless Pacemaker predecessor has a long-term retrieval success rate of 88% with helix fixation through 9 years regardless of implant duration.3
Retrieval Success by Implant Duration3
The specially designed retrieval catheter provides added confidence and is supported by a step-by-step retrieval protocol.4 AVEIR™ Leadless Pacemakers have an active fixation design that uses a screw-in mechanism to enable both implantation and long-term retrieval of the atrial and ventricular devices.1
Electrical Mapping Prior
to Fixation1,2
Designed to help reduce the number of repositioning attempts in the atrium and ventricle, AVEIR™ Leadless Pacemakers can assess Current of Injury via Commanded EGM, initial pacing capture thresholds, sensing amplitudes, and impedance in both atrial and ventricular chambers.
of patients had successful VENTRICULAR IMPLANTS WITH 1 OR LESS REPOSITIONING ATTEMPTS.2
of patients had successful ATRIAL IMPLANTS WITH 1 OR LESS REPOSITIONING ATTEMPTS.2
Proven Clinical Evidence2
Across 300 attempted implants, the procedure was successful in 295 patients for a
Dual Chamber Procedure Success Rate2
View safety and efficacy results observed at the three-month follow-up of the AVEIR™ DR i2i™ Study as cited in the New England Journal of Medicine.
*1.5V, 0.4ms, 60bpm, 300 ohms, 100% A pacing, 10% V pacing, i2i™ settings = 4 / 4.
References
- AVEIR™ Leadless Pacemakers and Delivery Catheter IFU, ARTEN600307044.
- Knops, Reinoud E., et al. "A Dual-Chamber Leadless Pacemaker." New England Journal of Medicine (2023). DOI: 10.1056/NEJMoa2300080
- Neuzil, Petr, et al. “Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers.” Journal of the American College of Cardiology, 2025.
- AVEIR™ Retrieval Catheter IFU. ARTMT600167676.
- Abbott. Data on file, Supplemental Longevity Assessments of AVEIR DR System. Item: 91070507.
MAT-2406381 v2.0